Security key
035255108
Anika Therapeutics, Inc. - Common Stock (ANIK)
CUSIP: 035255108
Q2 2026 13F Holders as of 30 Jun 2026
- Security type / class
- Equity / Common Stock
- Total 13F shares
- 560,301
- Total 13F value
- $8,770,261
- Share change
- +26,683
- SEC-reported price per share
- $14.63
- Number of holders
- 23
- Value change
- +$395,767
- Number of buys
- 13
- Number of sells
- 3
- Shares outstanding
- 13,317,495
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q2 2026
Institutions
23
Top holders
10
ANIK full security history
Ownership snapshot
Full 13F holder table
Previous quarter: Q4 2025
Anika Therapeutics, Inc. SEC filings
Anika Therapeutics, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 035255108
Recent filing periods:
Ownership snapshot
Top reported holders of ANIK - Anika Therapeutics, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Caligan Partners LP
Disclosed value leader
BlackRock, Inc.
Comparable rows
15/15
Latest evidence
30 Jun 2026
13F
13D/G
3/4/5
Lead comparable stake: 10%
13D/G row: Caligan Partners LP
Showing 1-6 of 15 holder rows.
Quick read
Caligan Partners LP leads the comparable SEC ownership view at 10%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Caligan Partners LP's linked filing trail.
Comparable ownership
Top 5
Caligan Partners LP
10%
BlackRock, Inc.
6.8%
VANGUARD CAPITAL MANAGEMENT LLC
5%
DIMENSIONAL FUND ADVISORS LP
4.5%
BlackRock Portfolio Management LLC
4.1%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Caligan Partners LP |
13F
13D/G
Company
|
10%
from 13D/G
|
$20,809,385
1,435,130 shares
|
— | 31 Mar 2026 |
| BlackRock, Inc. |
13F
13D/G
Company
|
6.8%
from 13D/G
|
$23,125,950
1,594,893 shares
|
— | 31 Mar 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC |
13D/G
13F
Vanguard Capital Management · Company
|
5%
|
$9,644,330
659,216 shares
|
-$533,717 | 30 Jun 2026 |
| DIMENSIONAL FUND ADVISORS LP |
13D/G
13F
Company
|
4.5%
|
$9,656,545
657,355 shares
|
$0 | 31 Dec 2024 |
| BlackRock Portfolio Management LLC |
13D/G
|
4.1%
|
$7,969,815
544,710 shares
|
-$3,638,058 | 30 Jun 2026 |
| Trigran Investments, Inc. |
13D/G
|
1.2%
|
$1,618,745
168,400 shares
|
-$13,965,184 | 31 Dec 2025 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q2 2026
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
23
Shares
560,301
Rows available
23
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q2 2026 vs Q4 2025 Across Filers
Q4 2025 holders
126
Q2 2026 holders
23
Holder diff
-103
| Investor | Q4 2025 Shares | Q2 2026 Shares | Share Diff | Share Chg % | Q4 2025 value | Q2 2026 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend